BiomX Inc. — Director's Dealing 2022

Feb 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-12-31

Reporting Person: Walton Thomas Layton (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-31	Common Stock, $0.0001 par value	J	3637846	—	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-31	Warrants to purchase Common Stock	$5	J	1875000	Disposed	2027-01-28	Common Stock (1875000)	Indirect

Footnotes

F1: The common stock and warrants to purchase common stock previously reported by the reporting person are no longer indirectly beneficially owned by such reporting person and the reporting person specifically disclaims beneficial ownership of the securities reported. The shares are directly held by SymBiosis, LLC, over which the reporting person exercises investment discretion, but does not possess voting or dispositive power.